History

A list of downloadable documents created during development.

Lymphoma (non Hodgkin's, relapsed, refractory) - pixantrone monotherapy: Equality Impact Assessment - guidance development

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation 2

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): NICE's response to consultees and commentator comments on the draft scope and provisional matrix

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final scope

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final matrix

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final matrix (superseded)

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final scope (superseded)

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): NICE response to comments on draft scope (superseded)

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): draft scope

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): provisional matrix